Discover essential insights into diagnosing and monitoring Geographic Atrophy (GA) in today’s clinical practice with the latest segment of the EURETINA IME video interview series.

Renowned experts, Drs. Arshad M. Khanani and David A. Eichenbaum, delve into critical considerations for early diagnosis of dry AMD and assessing risks for progression to GA.

Understanding the importance of timely intervention, Dr. Khanani and Dr. Eichenbaum provide valuable guidance on identifying key markers of dry AMD and gauging the likelihood of progression to GA. Their expertise offers practitioners a comprehensive approach to managing these complex conditions effectively.

To gain access to the full interview and explore further insights, ensure to watch the complete series here:

Part 1: Diagnosing and Monitoring GA in Today’s Practice

Independent medical education supported by Apellis, Iveric Bio (an Astellas Company) and Zeiss.